在患有扩散型2型慢性鼻炎的患者中,杜皮卢马布诱导的美
Fabio S Ryser1,2, Ayla Yalamanoglu3, Alan Valaperti3
1Department of Rheumatology and Immunology, University Hospital Bern, University of Bern, Bern, Switzerland.
Allergy
|August 7, 2023
概括
用dupilumab (一种抗IL-4Rα抗体) 治疗的2型慢性鼻炎患者中乙酸氨基基基的升高表明了积极的临床反应,并与特定的分子变化有关.
科学领域:
- 免疫学 免疫学 免疫学
- 炎症性疾病 炎症性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 杜皮卢马布是一种针对IL-4受体α (IL-4Rα) 的抗体.
- 它已批准用于治疗2型炎症疾病,包括喘,亚托皮炎和慢性鼻炎 (CRS).
- 在dupilumab治疗期间,血液中异氨基细胞的过渡性增加被观察到.
研究的目的:
- 为了评估在杜皮卢马布治疗期间血中异氨基细胞升高的临床影响.
- 为了调查在dupilumab治疗的患者中血中乙氨基酸细胞计数增加的潜在原因.
主要方法:
- 用dupilumab治疗的扩散型2型CRS患者的分析.
- 在多个时间点收集临床数据 (SNOT-22,TNPS) 和血液样本.
- 细胞因子测量,蛋白质组学,流动细胞计,以检测异osinophils上的受体表达.
主要成果:
- 在63.2%的患者中,基线叶绿素友爱症 (≥0.3G/L) 存在.
- 在接受dupilumab治疗的患者中,乙氨基酸细胞数增加了≥0.5G/L在30.9%的患者中.
- 较高的基线氨基酸与更好的SNOT-22得分相关;氨基酸升高没有对临床结果产生负面影响.
- VCAM-1降低,而IL-4和CXCR4显示了与氨基酸水平相关的特定变化.
结论:
- 在2型CRS患者中,乙氨基酸的增加与对dupilumab的良好反应相关.
- 基线IL-4的升高可能预测dupilumab诱导的过渡性阴.
- 乙基上VCAM-1,CD49d和CXCR4的下调可能解释dupilumab诱导的乙基.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
346
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
346
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
489
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
489
01:19Antiasthma Drugs: Leukotriene Modifiers
357
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
357
01:27Allergic Drug Reactions
876
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
876
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K